Search Results - Ala Abudayyeh
- Showing 1 - 20 results of 29
- Go to Next Page
-
1
-
2
Nuclear receptor 4A (NR4A) family – orphans no more by Stephen Safe, Un-Ho Jin, Benjamin Morpurgo, Ala Abudayyeh, Mandip Singh, Ronald B. Tjalkens
Published 2015Artigo -
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
Tolfenamic acid inhibits esophageal cancer through repression of specificity proteins and c-Met by Sabitha Papineni, Sudhakar Chintharlapalli, Mona Abdel Rahim, Syng‐Ook Lee, Robert C. Burghardt, Ala Abudayyeh, C. Baker, Luis Javier Herrera, Stephen Safe
Published 2009Artigo -
11
Cholangiocarcinoma: The Current Status of Surgical Options including Liver Transplantation by Abdullah Esmail, Mohamed Badheeb, Batool Wael Alnahar, Bushray Almiqlash, Yara Sakr, Bayan Khasawneh, Ebtesam Al-Najjar, Hadeel Al‐Rawi, Ala Abudayyeh, Yaser Rayyan, Maen Abdelrahim
Published 2024Artigo -
12
Pancreatic ductal adenocarcinoma: the latest on diagnosis, molecular profiling, and systemic treatments by Doaa Bugazia, Ebtesam Al-Najjar, Abdullah Esmail, Saifudeen Abdelrahim, Karen Abboud, Adham Abdelrahim, Godsfavour Umoru, Hashem A. Rayyan, Ala Abudayyeh, Ala‐Eddin Al Moustafa, Maen Abdelrahim
Published 2024Revisão -
13
Oncogenic microRNA‐27a is a target for anticancer agent methyl 2‐cyano‐3,11‐dioxo‐18β‐olean‐1,12‐dien‐30‐oate in colon cancer cells by Sudhakar Chintharlapalli, Sabitha Papineni, Maen Abdelrahim, Ala Abudayyeh, Indira Jutooru, Gayathri Chadalapaka, Fei Wu, Susanne U. Mertens‐Talcott, Kathy Vanderlaag, Sung Dae Cho, Roger Smith, Stephen Safe
Published 2009Artigo -
14
Incidence, predictors, and survival impact of acute kidney injury in patients with melanoma treated with immune checkpoint inhibitors: a 10-year single-institution analysis by Maen Abdelrahim, Omar Mamlouk, Heather Lin, Jamie S. Lin, Valda D. Page, Noha Abdel‐Wahab, Joshua T. Swan, Umut Selamet, Cassian Yee, Adi Diab, Wadi N. Suki, Ala Abudayyeh
Published 2021Artigo -
15
Utilization of Immunotherapy for the Treatment of Hepatocellular Carcinoma in the Peri-Transplant Setting: Transplant Oncology View by Maen Abdelrahim, Abdullah Esmail, Ashish Saharia, Ala Abudayyeh, Noha Abdel‐Wahab, Adi Diab, Naoka Murakami, Ahmed O. Kaseb, Jenny C. Chang, A. Osama Gaber, Rafik M. Ghobrial
Published 2022Revisão -
16
Infliximab for the treatment of patients with checkpoint inhibitor associated acute tubular interstitial nephritis by Jamie S. Lin, Omar Mamlouk, Umut Selamet, Amanda Tchakarov, William F. Glass, Rahul A. Sheth, Rachel M. Layman, Ramona Dadu, Noha Abdel‐Wahab, Maen Abdelrahim, Adi Diab, Cassian Yee, Ala Abudayyeh
Published 2021Artigo -
17
Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature by Noha Abdel‐Wahab, Houssein Safa, Ala Abudayyeh, Daniel H. Johnson, Van Anh Trinh, Chrystia M. Zobniw, Heather Lin, Michael K. Wong, Maen Abdelrahim, A. Osama Gaber, María E. Suärez-Almazor, Adi Diab
Published 2019Revisão -
18
Transplant Oncology: An Evolving Field in Cancer Care by Maen Abdelrahim, Abdullah Esmail, Ala Abudayyeh, Naoka Murakami, Ashish Saharia, Robert McMillan, David W. Victor, Sudha Kodali, Akshay Shetty, Joy Nolte Fong, Linda W. Moore, Kirk Heyne, A. Osama Gaber, Rafik M. Ghobrial
Published 2021Revisão -
19
Transplant Oncology: An Emerging Discipline of Cancer Treatment by Maen Abdelrahim, Abdullah Esmail, Ala Abudayyeh, Naoka Murakami, David W. Victor, Sudha Kodali, Yee Lee Cheah, Caroline J. Simon, Mazen Noureddin, Ashton A. Connor, Ashish Saharia, Linda W. Moore, Kirk Heyne, Ahmed O. Kaseb, A. Osama Gaber, Rafik M. Ghobrial
Published 2023Revisão -
20
Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience by Omar Mamlouk, Umut Selamet, Shana Machado, Maen Abdelrahim, William F. Glass, Amanda Tchakarov, Lillian W. Gaber, Amit Lahoti, Biruh Workeneh, Sheldon Chen, Jamie S. Lin, Noha Abdel‐Wahab, Jean Tayar, Huifang Lu, María E. Suärez-Almazor, Nizar M. Tannir, Cassian Yee, Adi Diab, Ala Abudayyeh
Published 2019Artigo
Search Tools:
Related Subjects
Medicine
Internal medicine
Cancer
Oncology
Immunotherapy
Acute kidney injury
Cancer research
Immunology
Transplantation
Biochemistry
Biology
Chemistry
Nivolumab
Renal function
Urology
Adverse effect
Apoptosis
Disease
Endocrinology
Gastroenterology
Gene
Immune checkpoint
Intensive care medicine
Liver transplantation
Surgery
Survivin
Biopsy
Cancer cell
Creatinine
Hepatocellular carcinoma